PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding PDS Biotechnology Corp changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 44 | 1 | 41 | −2 |
| Shares | 7.88M | 1.95M | 5.05M | −882.4K (−14.9%) |
| Value | $6.07M | $1.50M | $3.05M | −$1.51M (−33.1%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held PDS Biotechnology Corp at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 1,631,089 | $986.8K | 0.00% |
| Vanguard Fiduciary Trust Co | 307,311 | $185.9K | 0.00% |
| Nine Masts Capital Ltd | 67,507 | $40.8K | 0.01% |
| Two Sigma Securities, LLC | 31,481 | $19.0K | 0.00% |
| Vanguard Global Advisers, LLC | 12,546 | $7.59K | 0.00% |
| United Capital Financial Advisers, LLC | 12,000 | $7.26K | 0.00% |
| Beacon Investment Advisory Services, Inc. | 5 | $4 | 0.00% |
Sold out (9)
Institutions that held PDS Biotechnology Corp at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Squarepoint Ops LLC | 192,556 | $148.2K |
| Virtu Financial LLC | 32,099 | $25.0K |
| StoneX Group Inc. | 16,000 | $12.3K |
| First Manhattan Co | 15,000 | $11.5K |
| Ground Swell Capital, LLC | 14,703 | $11.3K |
| Citigroup Inc | 9,393 | $7.23K |
| Tower Research Capital LLC (TRC) | 2,220 | $1.71K |
| Bank of America Corp | 1,028 | $791 |
| Advisor Group Holdings, Inc. | 17 | $13 |
Not filed for Q1 2026 yet (1)
Institutions that held PDS Biotechnology Corp at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 1,950,946 | $1.50M |